Akebia Therapeutics
AKBA
#7122
Rank
A$0.63 B
Marketcap
$2.92
Share price
2.23%
Change (1 day)
67.06%
Change (1 year)

Akebia Therapeutics (AKBA) - Cash on Hand

Cash on Hand as of September 2024 : A$54.34 Million

According to Akebia Therapeutics's latest financial reports the company has A$54.34 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Akebia Therapeutics - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$63 M-52.61%
2022-12-31A$0.13 B-35.66%
2021-12-31A$0.20 B-40.87%
2020-12-31A$0.34 B65.65%
2019-12-31A$0.21 B-53.8%
2018-12-31A$0.45 B12.16%
2017-12-31A$0.40 B12.7%
2016-12-31A$0.36 B90.04%
2015-12-31A$0.19 B42.81%
2014-12-31A$0.13 B264.64%
2013-12-31A$36.49 M2211.29%
2012-12-31A$1.57 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$14.39 B 26,388.14%๐Ÿ‡บ๐Ÿ‡ธ USA
A$22.39 B 41,112.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$32.42 B 59,563.72%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.39 B 618.70%๐Ÿ‡บ๐Ÿ‡ธ USA